Patents by Inventor Stephen M. Paridon

Stephen M. Paridon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF IMPROVING MYOCARDIAL PERFORMANCE IN FONTAN PATIENTS USING UDENAFIL COMPOSITIONS
    Publication number: 20230095034
    Abstract: The present invention relates generally to the field of using udenafil or a pharmaceutically acceptable salt thereof in patients who have undergone the Fontan operation.
    Type: Application
    Filed: September 14, 2020
    Publication date: March 30, 2023
    Inventors: James Yeager, David J. Goldberg, Stephen M. Paridon
  • METHODS OF IMPROVING MYOCARDIAL PERFORMANCE IN FONTAN PATIENTS USING UDENAFIL COMPOSITIONS
    Publication number: 20220047601
    Abstract: The present invention relates generally to the field of using udenafil or a pharmaceutically acceptable salt thereof in patients who have undergone the Fontan operation.
    Type: Application
    Filed: November 24, 2020
    Publication date: February 17, 2022
    Inventors: James L. Yeager, David J. Goldberg, Stephen M. Paridon
  • Methods of improving myocardial performance in Fontan patients using udenafil compositions
    Patent number: 10653698
    Abstract: The present invention relates generally to the field of using udenafil or a pharmaceutically acceptable salt thereof in patients who have undergone the Fontan operation.
    Type: Grant
    Filed: February 2, 2018
    Date of Patent: May 19, 2020
    Assignees: Mezzion Pharma Co., Ltd., The Children's Hospital of Philadelphia
    Inventors: James L. Yeager, David J. Goldberg, Stephen M. Paridon
  • METHODS OF IMPROVING MYOCARDIAL PERFORMANCE IN FONTAN PATIENTS USING UDENAFIL COMPOSITIONS
    Publication number: 20190030038
    Abstract: The present invention relates generally to the field of using udenafil or a pharmaceutically acceptable salt thereof in patients who have undergone the Fontan operation.
    Type: Application
    Filed: September 28, 2018
    Publication date: January 31, 2019
    Applicants: Mezzion Pharma Co., Ltd., The Children's Hospital of Philadelphia, The Children's Hospital of Philadelphia
    Inventors: James L. Yeager, David J. Goldberg, Stephen M. Paridon
  • METHODS OF IMPROVING MYOCARDIAL PERFORMANCE IN FONTAN PATIENTS USING UDENAFIL COMPOSITIONS
    Publication number: 20190030037
    Abstract: The present invention relates generally to the field of using udenafil or a pharmaceutically acceptable salt thereof in patients who have undergone the Fontan operation.
    Type: Application
    Filed: September 28, 2018
    Publication date: January 31, 2019
    Inventors: James L. Yeager, David J. Goldberg, Stephen M. Paridon
  • Methods of improving myocardial performance in fontan patients using udenafil compositions
    Patent number: 10137128
    Abstract: The present invention relates generally to the field of using udenafil or a pharmaceutically acceptable salt thereof in patients who have undergone the Fontan operation.
    Type: Grant
    Filed: June 30, 2015
    Date of Patent: November 27, 2018
    Assignees: Mezzion Pharma Co., Ltd., The Children's Hospital of Philadelphia
    Inventors: James L. Yeager, David J. Goldberg, Stephen M. Paridon
  • METHODS OF IMPROVING MYOCARDIAL PERFORMANCE IN FONTAN PATIENTS USING UDENAFIL COMPOSITIONS
    Publication number: 20180169103
    Abstract: The present invention relates generally to the field of using udenafil or a pharmaceutically acceptable salt thereof in patients who have undergone the Fontan operation.
    Type: Application
    Filed: February 2, 2018
    Publication date: June 21, 2018
    Inventors: James L. Yeager, David J. Goldberg, Stephen M. Paridon